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Influence of 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol preference
and consumption in C57BL/6 male mice
Alaina M. Jaster1,2, Sam Gottlieb2,-4, Michael Miles2,4, Javier González-Maeso1
Departments of Physiology & Biophysics1, Pharmacology & Toxicology2, Program in Neuroscience3 and VCU Alcohol Research Center4

Introduction
Alcohol Use Disorder (AUD) alone effects nearly 6% of
the adult population within the United States. Few
treatments for AUD exist, with no new FDA-approved
therapeutic treatments within the last 15 years.
Additionally, the limited treatments we do have are
estimated to produce sustained abstinence in less than
20% of individuals.

Results
Figure 1. Effects of a moderate and high dose of DOI on ethanol
preference and consumption. Dotted lines represent injection of 2
mg/kg DOI on drinking Day 14 (start of week 5) and 5 mg/kg DOI on
Day 17 (start of week 6).

Psychedelics, such as lysergic acid diethylamide
(LSD), psilocybin and 2,5-dimethoxy-4iodoamphetamine (DOI) affect processes related to
cognition, perception and sensory processing. These
compounds are serotonergic agonists and act primarily
through the 5-HT2A receptor in the frontal cortex.
It has been demonstrated that serotonin has
modulatory effects on the mesolimbic pathway, which is
implicated in the neurobiology of addiction.

We hypothesized that a moderate dose of DOI would
decrease ethanol preference and consumption.
• DOI did not affect ethanol consumption or preference at the 2- or
24-hour measures compared to baseline (week prior to DOI
injection).
• The DOI-treated group showed no difference from the vehicletreated group after receiving an either moderate (2 mg/kg) or
high (5 mg/kg) dose of DOI.
• There was an overall interaction of time and treatment in both 2and 24-hour fluid consumption in the groups (2-way ANOVA; 2-h
total fluid [p=0.0343] and 24-h total fluid [p=0.0112]).
• Our results are most likely due to:
• Issues with group randomization - Mice were assigned
a group based on weights and average drinking values
from the last drinking day prior to the first DOI treatment
week.
• Not allocating the mice into low and high drinking
groups as seen is other experimental designs

Clinical findings have demonstrated the ability of
psilocybin to decrease alcohol consumption in heavy
drinkers and studies with rodent models have
suggested DOI and LSD have the ability to decrease
ethanol preference and consumption.
The present study aims to evaluate the effects of
psychedelic, 2,5-dimethoxy-4-iodoamphetamine (DOI),
on ethanol drinking behavior in adult male C57BL/6
mice.

• Further statistical analysis to determine the relationship of the
baseline behavior to the behavior seen following DOI needs to
be completed for further interpretation of results.

Methodology
Subjects 15 adult male C57BL/6 mice were kept on a reverse
light cycle and had food and water ad libitum.
Training Mice were trained on the two-bottle choice paradigm by
being given access to one bottle of 20% ethanol and one bottle
of water every other day (off days mice had two bottles of water)
for four weeks to obtain a baseline reading of drinking behavior.
Following these four weeks, mice were assigned to either the
treatment group or vehicle group based on weight and baseline
drinking behavior from the week prior to testing.
Testing On the first day of the fifth and sixth weeks, mice were
injected intraperitoneally with a dose of DOI (2 or 5 mg/kg) or
saline vehicle 30-minutes prior to access to 20% ethanol. These
DOI doses were chosen based on previous behavioral studies
and dose response curves. Ethanol was given using 15 ml glass
bottles with rubber stoppers. Liquid volumes were recorded prior
to putting bottles in the cages.

Conclusion

• More experiments are warranted before fully understanding how
psychedelics can alter behavioral phenotypes associated with
substance use disorder and alcoholism.
Figure 3. Comparison of average consumption, preference and
total fluid consumption for baseline, 2 mg/kg and 5 mg/kg DOI.
(Two-way ANOVA with multiple comparisons; α<0.05).
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